rs3025010

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003376.6(VEGFA):​c.963-892T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.366 in 403,106 control chromosomes in the GnomAD database, including 27,284 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 10185 hom., cov: 32)
Exomes 𝑓: 0.37 ( 17099 hom. )

Consequence

VEGFA
NM_003376.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.53

Publications

62 publications found
Variant links:
Genes affected
VEGFA (HGNC:12680): (vascular endothelial growth factor A) This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]
VEGFA Gene-Disease associations (from GenCC):
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.399 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003376.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VEGFA
NM_003376.6
MANE Select
c.963-892T>C
intron
N/ANP_003367.4
VEGFA
NM_001025366.3
c.963-892T>C
intron
N/ANP_001020537.2P15692-14
VEGFA
NM_001025367.3
c.963-892T>C
intron
N/ANP_001020538.2P15692-16

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VEGFA
ENST00000672860.3
MANE Select
c.963-892T>C
intron
N/AENSP00000500082.3P15692-13
VEGFA
ENST00000372055.9
TSL:1
c.963-892T>C
intron
N/AENSP00000361125.5P15692-14
VEGFA
ENST00000425836.9
TSL:1
c.962+922T>C
intron
N/AENSP00000388465.4A0A0A0MSH5

Frequencies

GnomAD3 genomes
AF:
0.368
AC:
55940
AN:
151880
Hom.:
10170
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.380
Gnomad AMI
AF:
0.445
Gnomad AMR
AF:
0.346
Gnomad ASJ
AF:
0.311
Gnomad EAS
AF:
0.294
Gnomad SAS
AF:
0.412
Gnomad FIN
AF:
0.408
Gnomad MID
AF:
0.343
Gnomad NFE
AF:
0.365
Gnomad OTH
AF:
0.349
GnomAD4 exome
AF:
0.365
AC:
91685
AN:
251104
Hom.:
17099
Cov.:
0
AF XY:
0.369
AC XY:
51744
AN XY:
140164
show subpopulations
African (AFR)
AF:
0.373
AC:
2789
AN:
7476
American (AMR)
AF:
0.356
AC:
8317
AN:
23344
Ashkenazi Jewish (ASJ)
AF:
0.292
AC:
2190
AN:
7498
East Asian (EAS)
AF:
0.291
AC:
2511
AN:
8618
South Asian (SAS)
AF:
0.413
AC:
21065
AN:
50958
European-Finnish (FIN)
AF:
0.400
AC:
4346
AN:
10860
Middle Eastern (MID)
AF:
0.340
AC:
861
AN:
2534
European-Non Finnish (NFE)
AF:
0.354
AC:
45312
AN:
127892
Other (OTH)
AF:
0.360
AC:
4294
AN:
11924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
2561
5121
7682
10242
12803
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
372
744
1116
1488
1860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.368
AC:
55999
AN:
152002
Hom.:
10185
Cov.:
32
AF XY:
0.372
AC XY:
27659
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.380
AC:
15773
AN:
41464
American (AMR)
AF:
0.346
AC:
5296
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.311
AC:
1077
AN:
3460
East Asian (EAS)
AF:
0.293
AC:
1510
AN:
5154
South Asian (SAS)
AF:
0.414
AC:
1996
AN:
4824
European-Finnish (FIN)
AF:
0.408
AC:
4317
AN:
10572
Middle Eastern (MID)
AF:
0.336
AC:
98
AN:
292
European-Non Finnish (NFE)
AF:
0.365
AC:
24794
AN:
67918
Other (OTH)
AF:
0.348
AC:
735
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1847
3694
5541
7388
9235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.352
Hom.:
17562
Bravo
AF:
0.360
Asia WGS
AF:
0.397
AC:
1379
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
9.1
DANN
Benign
0.89
PhyloP100
-1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3025010; hg19: chr6-43747577; COSMIC: COSV57878529; COSMIC: COSV57878529; API